Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00493831 · ClinicalTrials.gov registry record · NA
Analysis of Lipid Biomarkers of Exposure and Host Response
A NA study, sponsored by University of Nebraska.
- Terminated
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT00493831 is a NA study that was terminated before completion, run by University of Nebraska. The registered enrollment target is 24 participants.
The verdict
NCT00493831, a NA study, was terminated before completion, sponsored by University of Nebraska.
- TERMINATED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this prospective, open-label, clinical trial is to establish the feasibility and validity of exhaled breath condensate (EBC) biomarkers for use in studies designed to evaluate harm reduction strategies of smoking. This will be accomplished by measuring selected markers in EBC believed related to the pathogenesis of lung disease before and after a smoking cessation intervention.
Interventions
- DRUG nicotine polacrilex, transdermal system or inhaler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2005-08-23 |
| Est. Completion | 2007-09-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00493831
The ClinicalTrials.gov registry entry for NCT00493831 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which nicotine polacrilex, transdermal system or inhaler is the first listed.
NCT00493831 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00493831 about?
NCT00493831 is a clinical study titled "Analysis of Lipid Biomarkers of Exposure and Host Response". The purpose of this prospective, open-label, clinical trial is to establish the feasibility and validity of exhaled breath condensate (EBC) biomarkers for use in studies designed to evaluate harm reduction strategies of smoking. This will be accomplished by measuring selected markers in EBC believed...
What is the current status of trial NCT00493831?
This trial is currently terminated. It is a NA study. The enrollment target is 24 participants. The study started on 2005-08-23. Estimated completion is 2007-09-09.
What interventions are being tested in trial NCT00493831?
The interventions under investigation include: nicotine polacrilex, transdermal system or inhaler (DRUG).
Who is sponsoring clinical trial NCT00493831?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.